Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-23

FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Actavis Pharma's clotrimazole and betamethasone dipropionate topical product, indicating changes to its labeling…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clotrimazole and betamethasone dipropionate (clotrimazole and betamethasone dipropionate)

Snippet

SUPPL AP for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE (CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE)